by Tyler Wenzel | Nov 23, 2023
Cell therapies that replenish a healthy cell niche have long been an attractive approach to treat a variety of diseases, such as Parkinson’s disease, which are incurable and characterized by the loss of critical cell functions. The attractiveness of cell therapies is...
by Laine Bodnar | Nov 2, 2023
Working in science, whether in academia or industry, can be a rewarding yet challenging experience. For women pursuing careers in these fields, there are unique considerations and issues to be mindful of. As such, the Women in Science Breakfast at the 2023 Till &...
by Cal Strode | Aug 16, 2023
In a wide-ranging interview with POLITICO reporter Robert King at the Next Generation of Health Care Therapies event, Dr. Peter Marks, Director, Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA), discussed cell and gene...
by Stacey Johnson | Aug 4, 2023
It’s August already. For many, this means vacation time and soaking up as much summer as possible before work and life ramp up again in the fall. For me, August means multiple family birthdays ($) and the return of the blog carnival! What is a blog carnival you ask?...
by Kevin Robb | Jun 29, 2023
Mesenchymal stromal cells (MSCs) have been at the front line of cell therapy and regenerative medicine efforts for decades. Investigators hotly pursued MSCs as prospective cell therapies for a wide range of diseases, but enthusiasts were left wanting when several...
Comments